Resolved HBV and anti-CD20 therapy

被引：1
|
作者：
Hicks, Lisa K. [1 ]
Feld, Jordan J. [1 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
来源：
BLOOD | 2019年 / 133卷 / 02期
关键词：
PATIENTS RECEIVING RITUXIMAB; HEPATITIS-B REACTIVATION; LYMPHOMA; CHEMOTHERAPY;
D O I：
10.1182/blood-2018-11-882167
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In this issue of Blood, Kusumoto et al report that patients with resolved hepatitis B (hepatitis B surface antigen [HBsAg] negative, anti-hepatitis B core antibody [anti-HBcAb] positive) receiving obinutuzumab or rituximab-based treatment on the GOYA and GALLIUM studies experienced a substantial risk of hepatitis B virus (HBV) reactivation (10.8% if not administered prophylaxis).(1)
引用
收藏
页码：104 / 106
页数：5
相关论文
共 50 条
  • [1] HBV Care Map for Patients Receiving Anti-CD20 Therapy
    Liederman, Zachary
    Berinstein, Neil
    Crump, Michael
    Hwang, Jessica
    Janssen, Harry L. A.
    Kouroukis, C. Tom
    Leung, Patricia
    Lok, Anna
    Yim, Colina
    Zelenetz, Andrew D.
    Chan, Kelvin
    Feld, Jordan
    Hicks, Lisa K.
    [J]. BLOOD, 2017, 130
  • [2] Anti-CD20 therapy in rheumatoid arthritis
    Roll, P.
    Tony, H. -P.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2009, 68 (05): : 370 - +
  • [3] BLOCKING B-CELLS (ANTI-CD20/ANTI-CD20)
    Isenberg, David A.
    [J]. RHEUMATOLOGY, 2015, 54 : 1 - 1
  • [4] Development of anti-CD20 therapy for multiple sclerosis
    Bartok, Beatrix
    Silverman, Gregg J. J.
    [J]. EXPERIMENTAL CELL RESEARCH, 2011, 317 (09) : 1312 - 1318
  • [5] Anti-CD20 Therapy: Underutilizing A Seed for Success?
    Camargo, Alyssa
    Squire, Jacqueline
    Rank, Matthew
    Freeman, Catherine
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2022, 42 (SUPPL 1) : S53 - S53
  • [6] Anti-CD20 in lupus
    Isenberg, DA
    Leandro, MJ
    Ehrenstein, MR
    Edwards, JCW
    Manson, J
    Cambridge, G
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 27 - 28
  • [7] Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy
    Maillart, Elisabeth
    Todesco, Eve
    Assoumou, Lambert
    Beigneux, Ysoline
    Lubetzki, Catherine
    Papeix, Caroline
    De Paz, Raphael
    Dubessy, Anne-Laure
    Djebara, Siham
    Louapre, Celine
    Pourcher, Valerie
    [J]. JOURNAL OF NEUROLOGY, 2024, 271 (05) : 2871 - 2874
  • [8] Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy
    Elisabeth Maillart
    Eve Todesco
    Lambert Assoumou
    Ysoline Beigneux
    Catherine Lubetzki
    Caroline Papeix
    Raphael De Paz
    Anne-Laure Dubessy
    Siham Djebara
    Céline Louapre
    Valérie Pourcher
    [J]. Journal of Neurology, 2024, 271 : 2871 - 2874
  • [9] Anti-CD20 treatments and the lymphocyte membrane: Pathology for therapy
    Borisch, B
    Semac, I
    Soltermann, A
    Palomba, C
    Hoessli, DC
    [J]. VERHANDLUNGEN DER DEUTSCHEN GESELLSCHAFT FUR PATHOLOGIE 85. TAGUNG: PATHOLOGIE FUR DAS 21. JAHRHUNDERT, 2001, 85 : 161 - 166
  • [10] Should anti-CD20 be used as an immune reconstitution therapy?
    Smets, Ide
    Wokke, Beatrijs
    Smolders, Joost
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (02) : 308 - 310
12345